An enhanced CRISPR repressor for targeted mammalian gene regulation-Reference-Cited by-同舟云学术

An enhanced CRISPR repressor for targeted mammalian gene regulation

Published:2018-07-16 Issue:8 Volume:15 Page:611-616
ISSN:1548-7091
Container-title:Nature Methods
language:en
Short-container-title:Nat Methods

Author:

Yeo Nan Cher^ORCID,Chavez Alejandro^ORCID,Lance-Byrne Alissa,Chan Yingleong,Menn David,Milanova Denitsa,Kuo Chih-Chung,Guo Xiaoge,Sharma Sumana,Tung Angela,Cecchi Ryan J.,Tuttle Marcelle,Pradhan Swechchha,Lim Elaine T.,Davidsohn Noah,Ebrahimkhani Mo R.,Collins James J.,Lewis Nathan E.^ORCID,Kiani Samira^ORCID,Church George M.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Molecular Biology,Biochemistry,Biotechnology

Link

http://www.nature.com/articles/s41592-018-0048-5.pdf

Reference51 articles.

1. Cho, S. W., Kim, S., Kim, J. M. & Kim, J.-S. Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease. Nat. Biotechnol. 31, 230–232 (2013).

2. Cong, L. et al. Multiplex genome engineering using CRISPR/Cas systems. Science 339, 819–823 (2013).

3. Mali, P. et al. RNA-guided human genome engineering via Cas9. Science 339, 823–826 (2013).

4. Jinek, M. et al. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337, 816–821 (2012).

5. DiCarlo, J. E. et al. Genome engineering in Saccharomyces cerevisiae using CRISPR-Cas systems. Nucleic Acids Res. 41, 4336–4343 (2013).

Cited by 388 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CRISPRoff epigenetic editing for programmable gene silencing in human cells without DNA breaks;2024-09-09

2. Distinct tumor architectures and microenvironments for the initiation of breast cancer metastasis in the brain;Cancer Cell;2024-09

3. Super‐Enhancer Driven LIF/LIFR‐STAT3‐SOX2 Regulatory Feedback Loop Promotes Cancer Stemness in Head and Neck Squamous Cell Carcinoma;Advanced Science;2024-08-29

4. H3.3K122A results in a neomorphic phenotype in mouse embryonic stem cells;2024-08-27

5. The therapeutic implications of all-in-one AAV-delivered epigenome-editing platform in neurodegenerative disorders;Nature Communications;2024-08-23